Role of nitric oxide and TPEN, a potent metal chelator, in ischaemic and reperfused rat isolated hearts

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 7-8, 1998, Pages 496-502

  Ferdinandy, Peter ^a   Appelbaum, Yori ^b   Csonka, Csaba ^a   Blasig, Ingolf E ^c   Tosaki, Arpad ^d  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Cardionet Ltd   (Israel)

^c LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^d UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac function; Dysrhythmias; Ischaemia reperfusion; Isolation heart; Nitric oxide; Rat; TPEN

Indexed keywords

CHELATING AGENT; N,N,N',N' TETRAKIS(2 PYRIDYLMETHYL)ETHYLENEDIAMINE; NITRIC OXIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTRON SPIN RESONANCE; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; IN VITRO STUDY; MALE; NONHUMAN; RAT; REPERFUSION;

EID: 0031875560     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.tb02242.x     Document Type: Article

References (30)

1. Amezcua JL, Palmer RMJ, De Souza BM, Moncada S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br. J. Pharmacol. 1989; 97: 1119-24.
2. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2: 1057-8.
3. Kubes P, Granger DN. Nitric oxide modulates microvascular perme-ability. Am. J. Physiol. 1992; 262: H611-15.
4. Ferdinandy P, Szilvassy Z, Csont T et al. Nitroglycerin-induced protection of the ischemic myocardium in isolated working hearts of rats with vascular tolerance to nitroglycerin. Br. J. Pharmacol. 1995; 115: 1129-31.
5. Weyrich AS, Ma X, Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992; 86: 279-88.
6. Yao SK, Ober JC, Krishnaswami A et al. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 1992; 86: 1302-9.
7. Sato H, Zhao ZQ, McGee DS, Williams MW, Hammon JW, Vinten-Johansen J. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J. Thorac. Cardiovasc. Surg. 1995; 110: 302-14.
8. Tsao PS, Aoki N, Lefer DJ, Johnson G III, Lefer AM. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 1990; 82: 1402-12.
9. Ferdinandy P, Szilvassy Z, Balogh N et al. Nitric oxide is involved in active preconditioning in isolated working rat hearts. Ann. NY Acad. Sci. 1996; 793: 489-93.
10. Ferdinandy P, Szilvassy Z, Horvath LI et al. Loss of pacing-induced preconditioning in rat hearts: Role of nitric oxide and cholesterol-enriched diet. J. Mol. Cell. Cardiol. 1997; 29: 3321-33.
11. Morita K, Sherman MP, Buckberg GD et al. Studies of hypoxemic/ reoxygenation injury without aortic clamping: V. Role of the L-arginine-NO pathway: The nitric oxide paradox. J. Thorac. Cardiovasc. Surg. 1995; 110: 1200-11.
12. Stein B, Frank P, Schmitz W, Scholz H, Thoenes M. Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J. Mol. Cell. Cardiol. 1996; 28: 1631-9.
13. Woolfson RG, Patel VC, Neild GH, Yellon DM. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 1995; 91: 1545-51.
14. Lancaster JR, Langreh JM, Bergonia HA, Murase N, Simmons RL, Hoffman RA. EPR detection of heme and nonheme iron-containing protein nitrosilation by nitric oxide during rejection of rat heart allograft. J. Biol. Chem. 1992; 267: 10994-8.
15. Mordvintcev P, Mulsch A, Busse R, Vanin A. Online detection of nitric oxide formation in liquid aqueous phase by electron paramagnetic resonance spectroscopy. Anal Biochem. 1991; 199: 142-6.
16. Ferdinandy P, Das DK, Tosaki A. Pacing-induced ventricular fibrillation leading to oxygen free radical formation in aerobically perfused rat hearts. J. Mol. Cell. Cardiol. 1993; 25: 683-92.
17. Mülsch A, Mordvintcev P, Vanin A. Quantification of nitric oxide in biological samples by electron spin resonance spectroscopy. Neuroprotection 1992; 1: 165-73.
18. Zweier JL, Wang P, Kuppusamy P. Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J. Biol. Chem. 1995; 270: 304-7.
19. Luperchio S, Tamir S, Tannenbaum SR. NO-induced oxidative stress and glutathione metabolism in rodent and human cells. Free Radic. Biol. Med. 1996; 21: 513-19.
20. Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johansen J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 1993; 88: 2337-50.
21. Schlüter KD, Jakob G, Ruiz-Meana M, Garcia-Dorado D, Piper HM. Protection of reoxygenated cardiomyocytes against osmotic fragility by nitric oxide donors. Am. J. Physiol 1996; 271: H428-34.
22. Zhang X, Xie YW, Nasjletti A, Xu X, Wolin MS, Hintze TH. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation 1997; 95: 176-82.
23. Wang WZ, Matsumori A, Yamada T et al. Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis: A possible mechanism through inhibition of nitric oxide production. Circulation 1997; 95: 245-51.
24. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: Implication for endothelial injury from nitric oxide and Superoxide. Proc. Natl Acad. Sci. USA 1990; 87: 1620-4.
25. Geng Y, Hansson GK, Holme E. Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ. Res. 1992; 71: 1268-76.
26. Kostic MM, Schrader J. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ. Res. 1992; 70: 208-12.
27. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 1993; 329: 2002-12.
28. Karck M, Appelbaum Y, Schwalb H, Haverich A, Chevion M, Uretzky G. TPEN, a transition metal chelator, improves myocardial protection during prolonged ischemia. J. Heart Lung Transplant. 1992; 11: 979-85.
29. Pabla R, Buda AJ, Flynn DM et al. Nitric oxide attenuates neutrophil-mediated myocardial dysfunction after ischemia and reperfusion. Circ. Res. 1996; 78: 65-72.
30. Suzuki M, Inauen W, Kvietys PR et al. Superoxide mediates reperfusion-induced leukocyte-endothelial cell interaction. Am. J. Physiol. 1989; 257: H1740-5.